Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib) EP News Bureau Dec 16, 2020 Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis EP News Bureau Sep 25, 2020 Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution
